does medicaid cover glp-1 At the beginning of this year, Medi-Cal cut all coverage for GLP-1 medication for obesity treatment. Very disappointing news. But we must remember that we have other effective treatment options that we

Cardiovascular Actions and Clinical Outcomes With Glucagon Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors Circulation Retatrutide, a GIP, GLP 1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double blind, placebo and active controlled, parallel group, phase 2 trial conducted in the USA The Lancet GLP1 Receptor AgonistsEffects beyond Obesity and Diabetes GLP 1 Microdosing GLP 1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies